Dr. Nathaniel Hawkins Discusses the Link Between COPD, Serious CV Events

AstraZeneca recently shared new data from the EXACOS-CV study, which found an increased cardiopulmonary risk following chronic obstructive pulmonary disease (COPD) exacerbations. The study included more than 300,000 patients with COPD and demonstrated that patients who experienced an exacerbation had an increased risk of serious cardiovascular events in the first 6 months. The risk remained elevated for 1 year.

In this interview, DocWire News spoke with EXACOS-CV study investigator Dr. Nathaniel Hawkins, who analyzed the findings and highlighted the link between COPD and serious heart problems.